| Sep 25 |
Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024
|
| Sep 5 |
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
|
| Aug 15 |
Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
|
| Jul 31 |
Lumos Pharma Q2 2024 Earnings Preview
|
| Jun 4 |
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
|
| May 16 |
Lumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...
|
| May 15 |
Lumos Pharma, Inc. (LUMO) Q1 2024 Earnings Call Transcript
|
| May 15 |
Lumos Pharma GAAP EPS of -$1.29 misses by $0.11, revenue of $0.17M misses by $0.13M
|
| May 14 |
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
|
| May 14 |
Lumos Pharma Q1 2024 Earnings Preview
|
